Hematologic toxicity of mitomycin-c (MMC) administered every three weeks in monochemotherapy of patients with solid tumors.
D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*
D008937:Mitomycins; D016685:Mitomycin